# Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

> **NCT06112392** · NA · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Stellate Ganglion
- Parkinson Disease

## Interventions

- **DIAGNOSTIC_TEST:** Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）
- **DIAGNOSTIC_TEST:** Treatment （Oral standard anti-Parkinson's drugs）

## Key facts

- **NCT ID:** NCT06112392
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-28
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06112392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06112392, "Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06112392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*